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Abstract: Vascular smooth muscle cell (VSMC) motility is essential during both physiological
and pathological vessel remodeling. Although ageing has emerged as a major risk factor in the
development of cardiovascular disease, our understanding of the impact of ageing on VSMC motility
remains limited. Prelamin A accumulation is known to drive VSMC ageing and we show that
presenescent VSMCs, that have accumulated prelamin A, display increased focal adhesion dynamics,
augmented migrational velocity/persistence and attenuated Rac1 activity. Importantly, prelamin A
accumulation in proliferative VSMCs, induced by depletion of the prelamin A processing enzyme
FACE1, recapitulated the focal adhesion, migrational persistence and Rac1 phenotypes observed in
presenescent VSMCs. Moreover, lamin A/C-depleted VSMCs also display reduced Rac1 activity,
suggesting that prelamin A influences Rac1 activity by interfering with lamin A/C function at the
nuclear envelope. Taken together, these data demonstrate that lamin A/C maintains Rac1 activity in
VSMCs and prelamin A disrupts lamin A/C function to reduce Rac1 activity and induce migrational
persistence during VSMC ageing.
Keywords: prelamin A; migratory persistence; Rac1
1. Introduction
Ageing is the greatest risk factor in the development of cardiovascular disease yet the mechanisms
underlying vessel ageing and how ageing impinges on vascular cell function remain poorly
understood [1,2]. Vascular smooth muscle cells (VSMCs) are the major cell type of the arterial
wall and normally exist in a contractile, differentiated state to maintain vascular tone. However,
contractile VSMCs are not terminally differentiated and retain the ability to dedifferentiate to
a proliferative, migratory phenotype and enhanced VSMC motility is observed during development,
vessel repair and in adverse vessel remodeling associated with restenosis and atherosclerosis [3–5].
VSMC phenotypic transition involves dramatic actin remodeling which is regulated by Rho GTPase
signalling pathways [6,7]. Recent evidence demonstrates that Rac1 is essential for VSMC migration
and neointimal formation in vivo [8]. Moreover, Rac1 signalling is critical for switching between
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random and directionally persistent migration in a variety of cell types [9], although whether Rac1
performs this function in VSMCs remains unknown.
The nuclear lamina, a filamentous meshwork of A- (lamin A/C) and B- (lamins B1 and B2) type
lamins, has emerged as a regulator of cytoskeletal organisation and cell motility [10]. The A-type lamins
are mechanically coupled to the cytoskeleton via association with the linker of the nucleoskeleton
and cytoskeleton (LINC) complex, that spans the nuclear envelope (NE) via interactions between
giant nesprin isoforms on the outer nuclear membrane (ONM) and the sad1 and UNC84 (SUN)
domain containing proteins (SUN1 and SUN2) that span the inner nuclear membrane (INM) and
directly bind lamin A/C in the nucleoplasm [11]. Importantly, this mechanical coupling permits
transmission of biophysical signals between the cytoskeleton and lamins to regulate lamin A/C
organisation, gene transcription and nuclear deformability [12,13]. Lamin A is synthesized from the
precursor protein prelamin A that undergoes a series of post-translational modifications, including
farnesylation and proteolytic cleavage by FACE1 before mature lamin A is incorporated into the nuclear
lamina [14–17]. However, mutations that disrupt lamin A processing give rise to Hutchinson-Gilford
progeria syndrome (HGPS), a severe early ageing disease where patients have a toxic accumulation of
mutant prelamin A, progerin, that accelerates senescence by inducing nuclear stiffening and disrupting
nuclear integrity [18–22]. HGPS patients develop premature atherosclerosis due to VSMC dysfunction
and usually die of myocardial infarction or stroke in their second decade of life [23–25]. Importantly,
normal VSMCs exhibit an age-related depletion in FACE1, leading to impaired prelamin A processing
and subsequent prelamin A accumulation [26,27]. More recently, we have demonstrated that prelamin
A accumulates prior to senescence, during a presenescent growth phase, further supporting a role for
prelamin A in promoting VSMC ageing and senescence [28].
HGPS-derived fibroblasts display impaired cell motility, suggesting that coupling between the
nuclear lamina and the cytoskeleton is critical for efficient cell migration [29,30]. In agreement,
disruption of LINC complex integrity, either in Laminopathic patient derived fibroblasts or by the
over expression of the dominant negative nesprin KASH domain, triggers altered cell morphology
and attenuates cell motility [13,29,30]. We have previously shown that prelamin A accumulation
induces VSMC presenescence, yet whether age associated changes in NE architecture impact on VSMC
motility remains unknown [28]. Therefore, we investigated the impact of VSMC presenescence and
prelamin A accumulation on the morphology and migratory capacity of VSMCs. VSMC morphology,
focal adhesion (FA) organisation, Rac1 activity and motility were altered during in vitro VSMC
ageing. Importantly, prelamin A accumulation in proliferative VSMCs mirrored the FA, Rac1 activity
and motility changes observed in presenescent VSMCs, suggesting that the A-type lamins form a
feedback loop to influence Rac1 signalling and regulate the intrinsic migrational persistence during
VSMC ageing.
2. Materials and Methods
2.1. Cell Culture
VSMCs were isolated from medial explants of human aortic tissue as previously described [31].
The VSMCs used in this study were derived from a 35-year-old female (35F) and a 54-year-old male
(54M). VSMCs were cultured in M199 medium containing 20% fetal bovine serum. VSMCs were serially
passaged in vitro and collected at proliferative (passages ~6–10), presenescent (passages ~12–14) and
senescent (passage ~15+) growth stages, as described previously [27]. All culture medium was
complemented with 1% penicillin/streptomycin and 200 µM L-Glutamine. Dharmacon smart pool
control and FACE-1 specific small interfering RNA (siRNA) oligonucleotides were transfected into
cells with the use of HiPerfect transfection reagent (Qiagen, Hilden, Germany) and incubated for 72 h.
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2.2. Immunofluorescence Microscopy
For immunostaining, cells were fixed in 4% paraformaldehyde, permeabilised in 0.5% Nonidet
P-40 alternative in phosphate buffered saline (PBS) and blocked in 1% bovine serum albumin
(BSA) in PBS for 1 h. Cells were incubated with prelamin A (Santa Cruz, Dallas, TX, USA) or
vinculin (Sigma-Aldrich, St Louis, MO, USA) primary antibody in blocking solution overnight
at 4 ◦C. After washing with PBS, cells were incubated in fluorescence-conjugated secondary
antibody solution or Rhodamine phalloidin (Invitrogen) for 1 h before staining cell nuclei with
4′,6′-Diamidino-2-Pheylindoledihydrochloride (DAPI). Cells were washed and mounted onto slides
using Mowiol/Dabco media. Images were captured using a Zeiss Axioplan 2 light microscope and
Volocity software (Perkin Elmer, Waltham, MA, USA) was used to control image acquisition and
measure morphological parameters (area and circularity) by fluorescence detection.
2.3. Glutathione–S-Transferase (GST) Pull-Down
P21-associated kinase (PAK) is an immediate downstream effector of stimulated Rac1 and
was used in this experiment to assay Rac1 activity. BL-21s were transformed with GST-PAK-P21
Rho binding domain plasmid (Addgene #12217) and expression was induced by the addition of
1 mM Isopropyl β-D-1-thiogalactopyranoside for 2 h at 37 ◦C. Bacterial pellets were suspended
in PBS containing protease inhibitors, sonicated and proteins solubilised in 1% Triton-X for 1 h at
4 ◦C. Following centrifugation, recombinant protein was purified by incubating supernatant with
glutathione-sepharose beads for 30 min at room temperature GST-protein beads (50 µL of 50% slurry)
were incubated with 200 µg VSMC lysate on a rotator for 2 h at 4 ◦C and washed three times.
Bead-bound protein was eluted by boiling in β-mercaptoethanol sample buffer and Rac1 activity was
analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blot analysis.
2.4. Quantitative Polymerase Chain Reaction (qPCR) and Western Blot Analysis
FACE1 qPCR was performed as described previously [27]. For Western blotting, VSMCs were
harvested into lysis buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton) supplemented
with protease inhibitors. Cell lysates were sonicated and boiled in β-mercaptoethanol sample buffer
before being subjected to SDS-PAGE and Western blot analysis using prelamin A (C-20), lamin A/C
(N18) (Santa Cruz), emerin (Novus Biologicals., Oakville, ON, Canada), SUN2 (Abcam., Cambridge,
UK), vinculin (Sigma., St Louis, MO, USA), nesprin-2 CH3 (described previously [32]) and Rac1
(Millipore., Watford, UK) antibodies.
2.5. Time-Lapse Video Microscopy and Migration Analysis
Cells were sparsely seeded in wells of a culture plate 24 h prior to filming. Time-lapse imaging
was conducted using an Olympus IX81 microscope attached to a Hamamatsu Photonics Orca-R2
cooled CCD camera (Hamamatsu Photonics., Welwyn Garden City, UK). Phase contrast images were
captured at varying positions using a motorised stage (LUDL Electronic Products, Hawthorne, NY,
USA) every 5 min for 16 h. Individual cells were manually tracked throughout consecutive frames
using an ImageJ software plugin (ImageJ1, National Institutes of Health (NIH), Bethesda, MD, USA).
Using these x-y coordinates, migrational velocity and persistence were determined using Mathematica
6.0 (Wolfram Research Ltd., Witney, UK) custom-written notebooks kindly provided from Professor
Graham Dunn and Daniel Soong, King’s College London.
2.6. Interference Reflection Microscopy (IRM)
Cells were cultured on glass-bottom culture dishes (MatTek Ltd., Ashland, MA, USA) for 18–24 h.
IRM images were captured every 2 min using an incident light fluorescence attachment and a 63× oil
immersion objective. Images were processed using ImageJ software in a method modified from
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previous studies [33]. Firstly, an FFT band pass filter was applied to generate binary images, making
focal adhesions strikingly obvious against the background. Artifacts were removed manually by
selecting and inverting to colour-match the background. The cell leading edge was selected and ImageJ
measured the pixel count of individual focal adhesions. Composite images highlighted newly formed
focal adhesions against original focal adhesions. The pixel count of newly formed adhesions was then
expressed as a percentage of the total number of original pixels to give focal adhesion assembly (%).
2.7. Statistical Analysis
Data are presented as mean +/− SEM and p-values were calculated using paired (siRNA
depletion) or unpaired (proliferative/presenescent) two-tailed Student’s t tests (Prism5, GraphPad
Software Inc., La Jolla, CA, USA). One-way ANOVA with Bonferroni’s post-test were performed
on proliferative/presenescent/senescent and sicontrol/siFACE1/silamins A/C data (GraphPad
Prism software).
3. Results
3.1. Prelamin A Accumulation Drives Aged-Related Morphological Changes
Primary human VSMCs were serially passaged in vitro to model VSMC ageing. As described
previously, VSMCs have three distinct growth stages: an initial proliferative phase at early passage
numbers when growth rate is high and prelamin A level is low; a presenescent phase when growth
rate begins to subside and prelamin A accumulates; and finally, a senescent phase when proliferation
terminates and prelamin A levels persist [27]. Western blot analysis (WB) confirmed that presenescent
VSMCs possessed increased levels of prelamin A in the nuclear insoluble fraction compared to
proliferative VSMCs (Figure 1A). Confocal immunofluorescence microscopy (IF) confirmed that the
nuclei of presenescent VSMCs possessed increased prelamin A levels compared to their proliferative
counterparts (Figure 1B). Next, we assessed the impact of presenescence on LINC complex integrity
by performing IF using an antibody raised to the N-terminus of the nesprin-2 giant. IF revealed that
nesprin-2 localised to the nuclear envelope of proliferative VSMCs, however, in presenescent VSMCs,
nesprin-2 was mislocalised from the NE to the endoplasmic reticulum (Figure 1C). We next investigated
the impact of presenescence on VSMC morphology by analysing 2-independent VSMC lines. Analysis
revealed that presenescent VSMCs were larger and more elongated than their proliferative counterparts
(Figure 1D–F) and possessed larger and more elongated nuclei (Figure 1G,H).
To confirm that prelamin A influences VSMC morphology, we employed a FACE1 siRNA
mediated knockdown approach. QPCR and WB confirmed efficient depletion of FACE1 mRNA
and protein compared to controls (Figure 2A,B). Subcellular fractionation confirmed prelamin A
accumulation in the nuclear insoluble fraction of FACE1-depleted VSMCs (Figure 2C) and IF analysis
confirmed prelamin A accumulation in the nuclei of FACE1-depleted VSMCs (Figure 2D). Furthermore,
IF also revealed that nesprin-2 was mislocalised from the NE in FACE1-depleted VSMCs (Figure 2E).
IF analysis revealed FACE1-depleted VSMCs displayed no change in spread area but were more
elongated than control cells (Figure 2F–H), suggesting that prelamin A contributes to age associated
changes in VSMC morphology.




Figure 1. Characterisation of morphological changes during vascular smooth muscle cell (VSMC) 
ageing. (A) Western blot (WB) of cytoplasmic, nuclear soluble and nuclear insoluble fractionations of 
proliferative (P) and presenescent (PS) VSMCs; Representative confocal images of proliferative and 
presenescent VSMCs stained with (B) prelamin A (green) and 4’,6-diamidino-2-phenylindole (DAPI) 
(blue); (C) nesprin-2 CH3 (green) and DAPI (blue); (D) Rhodamine phalloidin (red) and DAPI (blue). 
Graphs show (E) cell area, (F) cell shape factor, (G) nuclear area and (H) nuclear shape factor of 
proliferative (P) and presenescent (PS) VSMCs based on the combined measurement of >300 VSMCs 
from two different isolates (54M, 35F) in three independent experiments (** p ≤ 0.01 and *** p ≤ 0.0001). 
Figure 1. Characterisation of morphological changes during vascular smooth muscle cell (VSMC)
ageing. (A) Western blot (WB) of cytoplasmic, nuclear soluble and nuclear insoluble fractionations
of proliferative (P) and presenescent (PS) VSMCs; Representative confocal images of proliferative
and presenescent VSMCs stained with (B) prelamin A (green) and 4’,6-diamidino-2-phenylindole
(DAPI) (blue); (C) nesprin-2 CH3 (green) and DAPI (blue); (D) Rhodamine phalloidin (red) and DAPI
(blue). Graphs show (E) cell area, (F) cell shape factor, (G) nuclear area and (H) nuclear shape factor of
proliferative (P) and presenescent (PS) VSMCs based on the combined measurement of >300 VSMCs
from two different isolates (54M, 35F) in three independent exp riments (** p≤ 0.01 and *** p≤ 0.0001).
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Figure 2. Prelamin A accumulation alters VSMC morphology. (A) Graph shows farnesylated proteins-
converting enzyme 1 (FACE1) mRNA levels in control and FACE1-depleted VSMCs determined by 
qPCR and represents the combined data from three independent experiments (** p ≤ 0.01); (B) WB for 
FACE1 levels in control and FACE1-depleted VSMCs; (C) WB of cytoplasmic, nuclear soluble and 
nuclear insoluble fractionations of control and FACE1-depleted VSMCs; Representative confocal 
images of control and FACE1-depleted VSMCs stained with (D) prelamin A (green) and DAPI (blue); 
(E) nesprin-2 CH3 (green) and DAPI (blue); (F) Rhodamine phalloidin (red) and DAPI (blue). Graphs 
show (G) cell area; (H) cell shape factor of control and FACE1-depleted VSMCs based on >300 VSMCs 
from three independent experiments (*** p ≤ 0.0001). 
3.2. Prelamin A Accumulation Promotes Focal Adhesion Reorganisation 
The above data suggest that prelamin A accumulation induces cytoskeletal reorganisation in 
VSMCs. As the actin cytoskeleton is tethered to the extracellular matrix (ECM) by focal adhesion 
complexes (FA), we next investigated whether prelamin A accumulation impacted on FA 
organisation. IF of vinculin stained VSMCs revealed FAs to be abundantly localised throughout 
proliferative VSMCs whereas presenescent VSMCs displayed fewer FAs that were redistributed to 
the cell periphery (Figure 3A–C). FAs were also more circular in presenescent compared with 
proliferative VSMCs (Figure 3D,E). Alterations in FA organisation reflect changes in FA dynamics, 
Figure 2. Prelamin A accumulation alters VSMC morphology. (A) Graph shows farnesylated
proteins-co verting enzyme 1 (FACE1) mRNA leve s in control and FACE1-depleted VSMCs
determined by qPCR and represents the combined data from three independent experiments
(** p ≤ 0.01); (B) WB f r FACE1 levels in control and FACE1-depleted VSMCs; (C) WB of cytoplasmic,
nuclear s l le and nuclear insoluble fractionations of control and FACE1-depleted VSMCs;
Representative confocal images of control and FACE1-depleted VSMCs stained with (D) prelamin A
(green) and DAPI (blue); (E) nesprin-2 CH3 (green) and DAPI (blue); (F) Rhodamine phalloidin (red)
and DAPI (blue). Graphs show (G) cell area; (H) cell shape factor of control and FACE1-depleted
VSMCs based on >300 VSMCs from three independent experiments (*** p ≤ 0.0001).
3.2. Prelamin A Accumulation Promotes Focal Adhesion Reorganisation
The above data suggest that prelamin A accumulation induces cytoskeletal reorganisation in
VSMCs. As the actin cytoskeleton is tethered to the extracellular matrix (ECM) by focal adhesion
complexes (FA), we next investigated whether prelamin A accumulation impacted on FA organisation.
IF of vinculin stained VSMCs revealed FAs to be abundantly localised throughout proliferative VSMCs
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whereas presenescent VSMCs displayed fewer FAs that were redistributed to the cell periphery
(Figure 3A–C). FAs were also more circular in presenescent compared with proliferative VSMCs
(Figure 3D,E). Alterations in FA organisation reflect changes in FA dynamics, so we next performed
interference reflection microscopy (IRM) to measure FA assembly. Presenescent VSMCs displayed
enhanced FA assembly, indicating that presenescent VSMCs possess fewer, more dynamic FAs
compared to proliferative and senescent VSMCs (Figure 3F,G).
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Representative IRM overlay images of proliferative, presenescent and senescent 35F VSMCs at t = 0 
min (green) and t = 20 min (red); (G) Graph shows focal adhesion assembly over a 20-min period and 
represents the combined data of 15–20 cells per group pooled from three independent experiments (* 
p ≤ 0.05). 
We next investigated whether prelamin A accumulation was specifically accountable for these 
changes in FA organisation. IF revealed that FAs were abundantly present throughout control 
VSMCs however, FACE1-depleted VSMCs displayed fewer focal adhesions (Figure 4A,B). 
Furthermore, similar to presenescent VSMCs, FAs in FACE1-depleted VSMCs were also more 
spherical than those of control VSMCs (Figure 4C). IRM showed that FACE1-depleted VSMCs also 
display increased FA dynamics compared to control VSMCs (Figure 4D,E). Collectively, this evidence 
suggests that prelamin A accumulation enhances FA dynamics during VSMC ageing. 
Figure 3. VSMC ageing influences focal adhesion organisation. (A) Representative confocal images of
proliferative and presenescent VSMCs stained for vinculin (green) and DAPI (blue); Scale bar represents
20 µm. Graphs show (B,C) focal adhesion (FA) number per cell and (D,E) FA circularity of 54M and
35F VSMC isolates respectiv ly. Data represent combin d data analysing 500–1000 focal adhesions
from >100 cells from three independent experiments (** p ≤ 0.01 and *** p 0.0001); (F) Representative
IRM overlay images of proliferative, presenescent and senescent 35F VSMCs at t = 0 min (green) and
t = 20 min (red); (G) Graph shows focal adhesion assembly over a 20-min period and represents the
combined data of 15–20 cells per group pooled from three independent experiments (* p ≤ 0.05).
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We next investigated whether prelamin A accumulation was specifically accountable for these
changes in FA organisation. IF revealed that FAs were abundantly present throughout control VSMCs
however, FACE1-depleted VSMCs displayed fewer focal adhesions (Figure 4A,B). Furthermore, similar
to presenescent VSMCs, FAs in FACE1-depleted VSMCs were also more spherical than those of
control VSMCs (Figure 4C). IRM showed that FACE1-depleted VSMCs also display increased FA
dynamics compared to control VSMCs (Figure 4D,E). Collectively, this evidence suggests that prelamin




Figure 4. Prelamin A accumulation triggers FA reorganisation. (A) Representative confocal images of 
control and FACE1-depleted VSMCs stained for vinculin (green) and DAPI (blue). Scale bars 
represent 20 μm; Graphs show (B) FA number per cell and (C) FA circularity of control and FACE1-
depleted VSMCs. Data represent combined data analysing more than 300 focal adhesions pooled from 
>50 cells per group from three independent experiments (* p ≤ 0.05 and *** p ≤ 0.0001); (D) 
Representative IRM overlay images of control and FACE1-depleted 35F VSMCs at t = 0 min (green) 
and t = 20 min (red); (E) Graph shows focal adhesion assembly over a 20-min period and represents 
the combined data of 15–20 cells per group pooled from three independent experiments (** p ≤ 0.01). 
3.3. VSMC Ageing and Prelamin A Accumulation Stimulate Migrational Persistence 
As FA dynamicity is indicative of a cell’s migratory capacity, we next used video time-lapse 
microscopy to capture random single cell migration and characterise the effect of ageing on VSMC 
migration. Presenescent VSMCs possessed increased migrational velocity compared to proliferative 
and senescent VSMCs (Figure 5A,B). Presenescent VSMC migration was also more directionally 
persistent than that of proliferative and senescent VSMCs (Figure 5A,C). These findings led us to test 
whether prelamin A accumulation specifically influenced cell migration. FACE1-depleted VSMCs 
exhibited no change to migrational velocity when compared with control VSMCs (Figure 5D,E). 
However, similar to presenescent VSMCs, FACE1-depleted VSMCs possessed enhanced migratory 
persistence compared with control cells (Figure 5D,F), confirming that prelamin A accumulation 
stimulates migrational persistence during VSMC ageing. 
Figure 4. Prelamin A accumulation triggers FA reorganisation. (A) Representative confocal images of
control and FACE1-depleted VSMCs stained for vinculin (green) and DAPI (blue). Scale bars represent
20 µm; Graphs show (B) FA number per cell and (C) FA circularity of ontrol and FACE1-depleted
VSMCs. Data represent combined data analysing more than 300 focal adhesi ns pooled from >50 c lls
per group from three independent experiments (* p ≤ 0.05 and *** p ≤ 0.0001); (D) Representative IRM
overlay images of control and FACE1-depleted 35F VSMCs at t = 0 min (green) and t = 20 min (red);
(E) Graph shows focal adhesion assembly over a 20-min period and represents the combined data of
15–20 cells per group pooled from three independent experiments (** p ≤ 0.01).
3.3. VSMC Ageing and Prelamin A Accumulation Stimulate Migrational Persistence
As FA dynamicity is indicative of a cell’s migratory capacity, we next used video time-lapse
microscopy to capture random single cell migration and characterise the effect of ageing on VSMC
migration. Presenescent VSMCs possessed increased migrational velocity compared to proliferative
nd senescent VSMCs (Figure 5A,B). Presenescent VSMC migration was also mor directi nally
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persistent than that of proliferative and senescent VSMCs (Figure 5A,C). These findings led us to test
whether prelamin A accumulation specifically influenced cell migration. FACE1-depleted VSMCs
exhibited no change to migrational velocity when compared with control VSMCs (Figure 5D,E).
However, similar to presenescent VSMCs, FACE1-depleted VSMCs possessed enhanced migratory
persistence compared with control cells (Figure 5D,F), confirming that prelamin A accumulation




Figure 5. In Vitro ageing and prelamin A accumulation stimulate VSMC migrational persistence. (A) 
Analysis of randomly migrating single proliferative, presenescent and senescent VSMCs; Graphs 
show (B) migrational velocity and (C) persistence of proliferative, presenescent and senescent 
VSMCs. Data are based on the analysis of 61 (senescent) and 108 (proliferative and presenescent) 
individually tracked cells pooled from three independent experiments (*** p ≤ 0.0001); (D) Analysis 
of randomly migrating single control and FACE1-depleted 35F VSMCs; Graphs show (E) migrational 
velocity and (F) persistence of control and FACE1-depleted VSMCS. Data are based on the analysis 
of 121 (control) and 118 (FACE1-depleted) individually tracked cells pooled from three independent 
experiments (* p ≤ 0.05). 
3.4. Prelamin A Accumulation Attenuates Rac1 Activity during VSMC Ageing 
Diminished activity of the small GTPase Rac1 has previously been demonstrated to promote 
migrational persistence, therefore, we investigated whether VSMC ageing and prelamin A 
accumulation alter Rac1 activity by performing GST pull-down experiments using the PAK-p21-
binding domain that interacts with GTP-Rac1. WB revealed that Rac1 activity was attenuated in 
presenescent (Figure 6A,B) and FACE1-depleted (Figure 6C,D) VSMCs compared to their 
proliferative and control VSMCs respectively. To test whether prelamin A may be acting by 
interfering with lamin A/C function, we depleted lamin A/C in VSMCs. GST-pull down analysis 
revealed that Rac1 activity was attenuated in lamin A/C-depleted VSMCs compared to control 
VSMCs (Figure 6C,D). Together, this evidence suggests that prelamin A accumulation interferes with 
lamin A/C function to stimulate VSMC migrational persistence by suppressing Rac1 activity. 
Figure 5. In Vitro ageing and prelamin A acc mulation sti late VSMC migrational persistence.
(A) Analysis of randomly migrating single proliferative, presenescent and senescent VSMCs; Graphs
show (B) migrational velocity and (C) persistence of proliferative, presenescent and senescent VSMCs.
Data are based on the analysis of 61 (senescent) and 108 (proliferative and presenescent) individually
tr cked cells pooled from three independent exp riments (*** p ≤ 0.0 01); (D) Analysis of r ndomly
migrating single control and FACE1-depleted 35F VSMCs; Graphs show (E) migrational velocity and
(F) persistence of control and FACE1-depleted VSMCS. Data are based on the analysis of 121 (control)
and 118 (FACE1-depleted) individually tracked cells pooled from three independent experiments
(* p ≤ 0.05).
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3.4. Prelamin A Accumulation Attenuates Rac1 Activity during VSMC Ageing
Diminished activity of the small GTPase Rac1 has previously been demonstrated to
promote migrational persistence, therefore, we investigated whether VSMC ageing and prelamin
A accumulation alter Rac1 activity by performing GST pull-down experiments using the
PAK-p21-binding domain that interacts with GTP-Rac1. WB revealed that Rac1 activity was
attenuated in presenescent (Figure 6A,B) and FACE1-depleted (Figure 6C,D) VSMCs compared to
their proliferative and control VSMCs respectively. To test whether prelamin A may be acting by
interfering with lamin A/C function, we depleted lamin A/C in VSMCs. GST-pull down analysis
revealed that Rac1 activity was attenuated in lamin A/C-depleted VSMCs compared to control VSMCs
(Figure 6C,D). Together, this evidence suggests that prelamin A accumulation interferes with lamin
A/C function to stimulate VSMC migrational persistence by suppressing Rac1 activity.Cells 2016, 5, 41 10 of 13 
 
 
Figure 6. Prelamin A accumulation attenuates Rac1 activity. Glutathione-S-transferase (GST) pull-
down assay using the GST-p21-associated protein-p21 Rho binding domain to precipitate GTP-bound 
Rac1 from (A) proliferative and presenescent 54M and 35F VSMCs and (C) control, FACE1- and lamin 
A/C-depleted VSMCs. Graphs show densitometry measurements of Active-Rac1/total-Rac1 ratios of 
(B) proliferative and presenescent VSMCs and (D) control, FACE-1- and lamin A/C-depleted VSMCs 
derived from three independent experiments (* p ≤ 0.05 and ** p ≤ 0.01). 
4. Discussion 
The actin cytoskeleton regulates numerous cellular processes, including contractility, motility 
and proliferation, and age-related alterations to cytoskeletal organisation are detrimental to general 
VSMC functioning and cell fate [34,35]. Lamin A/C is indirectly coupled to F-actin via the LINC 
complex and disruption of either lamin A/C or the LINC complex induces cytoskeletal reorganisation 
and changes in cell motility [11,13,36,37]. VSMC ageing is driven by prelamin A accumulation and 
we show that presenescent VSMCs display changes in morphology that are indicative of cytoskeletal 
reorganisation [27]. FACE1-depletion induced prelamin A accumulation in proliferative VSMCs and 
recapitulated the elongated spindle-like morphology displayed by presenescent VSMCs. We have 
previously shown that presenescent and FACE1-depleted VSMCs stain positive for Ki67, suggesting 
that morphology changes induced by prelamin A are not due to cells exiting the cell cycle [27]. In 
addition to the morphology changes, we also show that prelamin A accumulation stimulated intrinsic 
migrational persistence of presenescent and FACE1-depleted VSMCs. 
Importantly, we show for the first time that prelamin A accumulation attenuates activity of the 
small GTPase Rac1. Previous studies have demonstrated that Rac1 activity serves as a switch between 
random and directionally persistent migration and reduced Rac1 activity promotes migrational 
persistence in a variety of cell types [9]. This suggests that prelamin A accumulation attenuates Rac1 
activity to promote migrational persistence during VSMC ageing. However, as prelamin A levels 
continue to increase and VSMCs enter senescence, migrational persistence subsides, suggesting that 
the impact of prelamin A on VSMC migration is dose dependent. Although further experimentation 
is required to elucidate the mechanism of how prelamin A accumulation influences Rac1 activity, we 
show that VSMCs depleted of lamin A/C also displayed reduced Rac1 activity, suggesting that 
prelamin A accumulation interferes with lamin A/C function at the NE. Lamin A/C is critical for 
nuclear organisation and provides structural support to the NE [38,39]. Progerin accumulation has 
been shown to disrupt nuclear organisation/mechanics in HGPS-derived fibroblasts and potentially 
these lamin A/C functions are also impaired by prelamin A accumulation during VSMC ageing [40]. 
In agreement with this notion, we have previously shown that nuclear morphology and 
Figure 6. Prelamin A accumulation attenuates Rac1 activity. Glutathione-S-transferase (GST) pull-down
assay using the GST-p21-associated protein-p21 Rho binding domain to precipitate GTP-bound Rac1
from (A) proliferative and presenescent 54M and 35F VSMCs and (C) control, FACE1- and lamin
A/C-depleted VSMCs. Graphs show densitometry measurements of Active-Rac1/total-Rac1 ratios of
(B) proliferative and presenescent VSMCs and (D) control, FACE-1- and lamin A/C-depleted VSMCs
derived from thre ind pendent experime ts (* p ≤ 0.05 and ** p ≤ 0.01).
4. Discussion
The actin cytoskeleton regulates numerous cellular processes, including contractility, motility and
proliferation, and age-related alterations to cytoskeletal organisation are detrimental to general VSMC
functioning and cell fate [34,35]. Lamin A/C is indirectly coupled to F-actin via the LINC complex
and disruption of either lamin A/C or the LINC c mplex induces cytoskelet l reorganisation and
changes i cell motility [11,13, 6,37]. VSMC ageing is driven by prelamin A accumul tion and we
show that presenescent VSMCs display changes in morphology that are indicative of cytoskeletal
reorganisation [27]. FACE1-depletion induced prelamin A accumulation in proliferative VSMCs and
recapitulated the elongated spindle-like morphology displayed by presenescent VSMCs. We have
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previously shown that presenescent and FACE1-depleted VSMCs stain positive for Ki67, suggesting
that morphology changes induced by prelamin A are not due to cells exiting the cell cycle [27].
In addition to the morphology changes, we also show that prelamin A accumulation stimulated
intrinsic migrational persistence of presenescent and FACE1-depleted VSMCs.
Importantly, we show for the first time that prelamin A accumulation attenuates activity of the
small GTPase Rac1. Previous studies have demonstrated that Rac1 activity serves as a switch between
random and directionally persistent migration and reduced Rac1 activity promotes migrational
persistence in a variety of cell types [9]. This suggests that prelamin A accumulation attenuates
Rac1 activity to promote migrational persistence during VSMC ageing. However, as prelamin
A levels continue to increase and VSMCs enter senescence, migrational persistence subsides,
suggesting that the impact of prelamin A on VSMC migration is dose dependent. Although further
experimentation is required to elucidate the mechanism of how prelamin A accumulation influences
Rac1 activity, we show that VSMCs depleted of lamin A/C also displayed reduced Rac1 activity,
suggesting that prelamin A accumulation interferes with lamin A/C function at the NE. Lamin A/C
is critical for nuclear organisation and provides structural support to the NE [38,39]. Progerin
accumulation has been shown to disrupt nuclear organisation/mechanics in HGPS-derived fibroblasts
and potentially these lamin A/C functions are also impaired by prelamin A accumulation during VSMC
ageing [40]. In agreement with this notion, we have previously shown that nuclear morphology and
heterochromatin alterations in aged VSMCs mimic those observed in HGPS-derived fibroblast cells [27].
Moreover, as integrin disruption has also been shown to disrupt Rac1 activity and induce migrational
persistence, it is easy to envisage a mechanism whereby the LINC complex relays biophysical
signals, derived from changes in nuclear mechanics, to F-actin and FAs to regulate Rac1 activity [9].
In agreement with this notion, we show that prelamin A accumulation triggered mislocalisation of
nesprin-2 from the nuclear envelope in VSMCs. Clearly, further experimentation is now required to
investigate the role of the LINC complex in regulating Rac1 activity and migrational persistence.
Changes in Migrational Persistence during VSMC Ageing
In this current study, we analysed the migrational capacity of the three distinct VSMC growth
phases termed proliferative, presenescence and senescence, using healthy VSMCs derived from a
35-year-old and 54-year-old donor. We have previously shown that VSMCs isolated from 70+ year old
donors possess less proliferative capacity and are presenescent in tissue culture [27]. Importantly,
a significant population of VSMCs in aortae of aged (70+ years) donors display prelamin A
accumulation, stain positive for Ki67 and negative for senescence associated β-galactosidase activity,
confirming that presenescent VSMCs exist in vivo [27]. In this current study, we show that single
proliferative VSMCs were relatively slow and lacked migratory persistence which fits with earlier
studies illustrating that VSMCs are slow-moving cells that exhibit random migration patterns [41,42].
Lack of migratory persistence suggests that young, healthy VSMCs within the vessel wall are dispersive
with an explorative nature. Interestingly, presenescent VSMCs migrated more rapidly and persistently,
indicative of more efficient directional migration. Ultimately, when VSMCs reached senescence,
migration rates slowed. The inability of senescent VSMCs to conduct their migratory functions
within the vessel may be detrimental to vascular health. Normally, VSMC migration is fundamental
for vessel repair and VSMCs are a prominent cell-type at atherosclerotic sites where they aid the
formation of a protective cap to stabilise rupture-prone lesions [42–44]. Increased VSMC migration,
coupled with enhanced ECM deposition drives vessel remodeling and intimal thickening, which
are major pathogenic factors in atherosclerotic plaque development [45–47]. We hypothesise that
the enhancement of VSMC migration is primarily a protective mechanism allowing presenescent
VSMCs a final attempt to repair vessel damage with a migratory ‘boost’ before they become senescent.
Ultimately, when VSMCs reach senescence, migration and proliferation rates diminish, resulting in
reduced recruitment of VSMCs to sites of vascular injury.
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